National

Pro Rata

Axios Pro Rata

America has become a two-vaccine nation, but plenty of other companies are continuing to work on new vaccines that could increase supply and accelerate the country's goal of herd immunity.

Axios Re:Cap digs into the vaccine pipeline with Derek Lowe, a medicinal chemist and biotech blogger.

The vaccine pipeline, beyond Pfizer and Moderna

America has become a two-vaccine nation, but more products could be on their way.

Health Care

Coronavirus vaccines

Business

Axios Re:Cap

Coronavirus

<p>America has become a two-vaccine nation, but plenty of other companies are continuing to work on new vaccines that could increase supply and accelerate the country&#x27;s goal of herd immunity.</p><p><strong>Axios Re:Cap</strong> digs into the vaccine pipeline with Derek Lowe, a medicinal chemist and biotech blogger.</p><div><div><iframe frameborder="no" height="200" scrolling="no" src="https://playlist.megaphone.fm?e=AXIOS1109298919" width="100%"></iframe></div><div style="display:none"></div></div><span data-ad-status="NO_AD_LENGTH" data-ad-type="midStoryAd"></span>

Podcasts

The U.S. faces a range of health care flashpoints — unaffordable drugs, opioids, vaping — as we debate whether to adopt universal care. For now, the Affordable Care Act is the law of the land, but Republicans want to issue it a final death blow.

Health

After a record economic expansion, the coronavirus pandemic sent the U.S. economy into a recession as unemployment soared to staggering heights. The country now faces urgent questions about how much stimulus is needed for reeling consumers and businesses, and what a recovery might look like.

The vaccine pipeline, beyond Pfizer and Moderna

Go deeper